A Randomised, Double-blind Placebo-controlled Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of MIV-711 in Knee Joint Osteoarthritis

Trial Profile

A Randomised, Double-blind Placebo-controlled Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of MIV-711 in Knee Joint Osteoarthritis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2017

At a glance

  • Drugs MIV 711 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Medivir AB
  • Most Recent Events

    • 12 Jul 2017 This trial was completed in Bulgaria (end date: 2017-05-23), according to European Clinical Trials Database.
    • 04 Jul 2017 The trial has been completed in Germany as per European Clinical Trials Database; global end date 23 may 2017.
    • 28 Apr 2017 According to a Medivir AB media release, the company expects to present the data from the study in the third quarter of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top